跳至主要内容
临床试验/NCT06039462
NCT06039462已完成不适用

Improve Patient Safety and Wellbeing in Leeds Children Hospital for Patients Undergoing Procedures Through Use of Virtual Reality Distraction Therapy (VRDT), and Improve Their Overall Experience.

The Leeds Teaching Hospitals NHS Trust2 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2021年9月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
108
试验地点
2
主要终点
Reduction in fear and anxiety associated with treatment.

研究概览

简要总结

For many children in hospital, having blood tests or cannulation is a significantly distressing event physically, psychologically and emotionally. Use of distraction during invasive procedures is already common practice in paediatrics to improve the experience both for the child and parents. Use of Virtual Reality (VR) and VR Distraction Therapy (VRDT) is a relatively new concept, but has already shown promising results in studies.

"VR offers an interactive distraction technique, a contrast to the passive distraction of reading a book or playing games on a tablet ... and [VR] is thought to alter pain perception and the child's interpretation of pain signals." (Cochrane Library - Virtual reality simulation for reducing pain in children).

The project aims to collect data about venepuncture, cannulation, long lines - qualitative and quantitative data - from children and parents. This studyl compares current standard practice with VR distraction therapy.

详细描述

Not all studies raise significant issues. Some studies may have straightforward ethical or other issues that can be identified and managed routinely. Others may present significant issues requiring further consideration by a REC, HRA, or other review body (as appropriate to the issue). Studies that present a minimal risk to participants may raise complex organisational or legal issues. You should try to consider all the types of issues that the different reviewers may need to consider.

VR companies do not recommend use of their headsets in children under 13 years of age. I do not anticipate including 8-12 year olds in the study causing any issues based on experience and advice from relevant experts (see below). In summary, the age cut off is borne of lack of evidence for long-term effects of VR on visual or brain development, rather than specific concerns or evidence existing to inform the age cut off.

Children's Hospital Colorado (US) use VR in children of 6 years and above. Speaking with their Associate Professor of Paediatrics, the age limitation is not derived from medical standards or concerns. They discussed with their Neurology department who agreed there is no age-specific concern that warrants the 12 year cut-off, and they also rely upon the professional expertise of Child Life Specialists who routinely screen toys and devices for age-appropriate application. They have used VR in healthcare for children several hundred times and have no concerns about the age cut off the VR companies suggest.

Stanford University School of Medicine (US) run the highest volume clinical VR therapy program in the US, with thousands of children each year receiving VR. Their department similarly does not exclude under 13 year olds from their program.

Clinicians experienced with VR in the UK have spoken to VR companies involved in their studies, and the information gives was that there no long-term data on VR and its effects on brain and visual development. These clinicians also use VR on children aged 5-6 years and above.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
8 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Paediatric patient, aged 8-12 years or 13-18 years.
  • Under care of paediatric department - as inpatient
  • Requiring invasive procedure - including (but not limited to) blood sampling (venepuncture), siting intravenous access (cannulation, long line, Port-a-cath access), lumbar puncture, other device insertion or removal (e.g. catheter, drain, cardiac pacing wires, intra-thecal baclofen pump refills), minor surgical bedside procedures.
  • Consents to study - either child with mental capacity, or parent/legal guardian on behalf of their child.

排除标准

  • Participants will not be recruited if they or their parent/guardian believe the child will not engage or cannot engage with procedural distraction.
  • Participants will not be recruited to the VR group if he/she meets any of the following exclusion criteria:
  • Patients not under care of paediatrics (over 18 years of age)
  • If the child has previously been recruited to the study - each child may only be in the study once
  • Contraindications to use of VR or the VR headset
  • Inability to wear headset - facial or skull injury/fracture
  • Marked reduced visual acuity or blindness
  • Interference with care - e.g. requirement of other medical equipment that cannot be worn/administered simultaneously with VR e.g. non-invasive ventilation.
  • Pre-procedure dizziness, nausea, vertigo
  • History of photosensitive epilepsy
  • Potential for poor cooperation with procedure (hence risk of moving) - this is more likely in the age range 8-12 years old. Prior discussion to be held with parents through PIL and consent form to judge if the child is likely to be cooperative.

结局指标

主要结局

Reduction in fear and anxiety associated with treatment.

时间窗: 24 hours

Questionnaire (x1) completed at the time of intervention

次要结局

未报告次要终点

研究者

发起方
The Leeds Teaching Hospitals NHS Trust
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验